Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia


Liu KC, Mulindwa J, Giganti MJ, Putta NB, Chintu N, Chi BH, Stringer JS, Stringer EM


J Acquir Immune Defic Syndr 2011; 57(5): e101-5



In resource-limited settings, CD4 testing is a barrier to antiretroviral therapy initiation in pregnancy.


We used logistic regression to identify predictors of CD4 cell count ≤ 350 cells/uL in 20,233 pregnant women.


The best-performing model included any 3 of: age ≥ 28 years old, hemoglobin ≤ 9.8 g/dL, gestational age ≤ 30 weeks, weight ≤ 64 kg, history of tuberculosis or previous death of an infant prior to one year old. Sensitivity was 45.7% (95% CI: 44.5-47.0), specificity 70.7% (95% CI: 69.6-71.8), and misclassification rate 41.4% (95% CI: 40.5-42.2).


CD4 triage remains a critical element of maternal HIV care and PMTCT.

Leave a Reply

Your email address will not be published. Required fields are marked *